This web site is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

CBP/P300 Inhibitor (Aurigene)

Aurigene Discovery Technologies

Description: Aurigene lists a CBP/P300 asset in its pipeline. We will update this record as more information as it becomes available.


CBP/P300 Inhibitor (Aurigene) News


Additional information available to subscribers only:

  • Targets
  • Routes
  • Catalysts
  • Designations
  • Events

Request a Free Demo Subscriber Login Search for another drug